| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

Community Health Systems, Inc. (NYSE: CYH) Surpasses Earnings Estimates

Community Health Systems, Inc. (NYSE:CYH) is a prominent player in the healthcare sector, specifically within the Zacks Medical - Hospital industry. The company operates a network of hospitals and healthcare facilities across the United States, providing a range of medical services. CYH competes with other healthcare providers in delivering quality care and maintaining financial stability.

On February 18, 2026, CYH reported its earnings, showcasing an impressive earnings per share (EPS) of $0.80, which significantly exceeded the estimated EPS of -$0.20, reflecting a substantial improvement from the previous year's loss of $0.42 per share. The company has consistently surpassed consensus earnings estimates in three of the last four quarters.

Despite reporting a revenue of approximately $3.106 billion, which was slightly below the estimated $3.137 billion, CYH's financial performance remains noteworthy. The revenue for the quarter ending December 2025 fell short of the Zacks Consensus Estimate by 1.18%, yet the company has exceeded consensus revenue estimates three times in the last four quarters. This indicates a strong track record of financial performance.

CYH's financial health is further demonstrated by its net income attributable to stockholders, which reached $110 million, translating to $0.81 per diluted share. This marks a significant turnaround from the previous period's net loss of $70 million. The company's price-to-earnings (P/E) ratio of approximately 0.88 and price-to-sales ratio of about 0.037 suggest a relatively low valuation compared to its earnings and sales.

The company's liquidity position is solid, with a current ratio of about 1.46, indicating its ability to cover short-term obligations. However, the debt-to-equity ratio is negative at approximately -0.79, showing more liabilities than equity. Despite this, CYH's enterprise value to sales ratio of around 0.069 and enterprise value to operating cash flow ratio of approximately 1.59 reflect a reasonable valuation in relation to its sales and cash flow.

Published on: February 19, 2026